Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares

$2.90
+0.00 (+0.00%)

Market Capitalization:

$6.21M

Can-Fite BioPharma , each representing three hundred (300) Price Chart

Can-Fite BioPharma , each representing three hundred (300) Price Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM2.962.952.942.932.922.912.90

Can-Fite BioPharma , each representing three hundred (300) Volume Chart

Can-Fite BioPharma , each representing three hundred (300) Volume Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM1.00K857714571429286143

Can-Fite BioPharma , each representing three hundred (300) Market Segments

Premarket

*No Trades in Segment

After Hours Yesterday

-0.06(-2.03%)
Open$2.96
Close$2.90
Low$2.90
Low Change-0.06 (-2.03%)
High$2.96
High Change+0.00 (+0.00%)
Range$0.06
Volume1.994K
Dollar Volume$5.78K

Regular Trading Hours Yesterday

-0.08(-2.68%)
Open$2.98
Close$2.90
Low$2.90
Low Change-0.08 (-2.68%)
High$2.98
High Change+0.00 (+0.00%)
Range$0.08
Volume8.49K
Dollar Volume$24.62K

Premarket Yesterday

+0.00(+0.00%)
Open$2.92
Close$2.92
Low$2.92
Low Change0.00 (0.00%)
High$2.92
High Change+0.00 (+0.00%)
Range$0.00
Volume422
Dollar Volume$1.23K

Can-Fite BioPharma , each representing three hundred (300) Moving Averages

5 Day Moving Average (SMA5)$2.94
10 Day Moving Average (SMA10)$3.00
20 Day Moving Average (SMA20)$3.02
50 Day Moving Average (SMA50)$3.64
100 Day Moving Average (SMA100)$4.15
200 Day Moving Average (SMA200)$8.11

Can-Fite BioPharma , each representing three hundred (300) Statistics

Average Volume (30 Days)
P/E Ratio (Current)
EPS (Current)
Dividend Yield
Free Cash Flow
Cash Ratio
Current Ratio
Quick Ratio
Debt to Equity
Enterprise Value
EV to EBITDA
EV to Sales
Price to Book
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets
Return on Equity

Can-Fite BioPharma , each representing three hundred (300) Stock Splits

There have been 3 stock splits for Can-Fite BioPharma , each representing three hundred (300) (CANF). The last reverse stock split occured on January 5, 2026 and reduced the outstanding shares at a ratio of 20:1.

DateTypeRatio
Jan 5, 2026Reverse20:1
Jan 9, 2023Reverse10:1
May 10, 2019Reverse15:1

Can-Fite BioPharma , each representing three hundred (300) Dividends

There have been no dividends for Can-Fite BioPharma , each representing three hundred (300) (CANF).